Shiro Akinaga
Chief Executive Officer at NANO MRNA CO.,LTD.
Net worth: 96 274 $ as of 2024-03-30
Profile
Shiro Akinaga is currently the President, CEO & Representative Director at NANO MRNA Co., Ltd.
since 2022.
He is also the Chairman & Chief Executive Officer at AccuRna, Inc. since 2017.
Previously, he worked at Kyowa Kirin Co., Ltd.
as an Executive Officer & Manager-Overseas Development.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NANO MRNA CO.,LTD.
0.11% | 2023-03-30 | 78,760 ( 0.11% ) | 96 274 $ | 2024-03-30 |
Shiro Akinaga active positions
| Companies | Position | Start |
|---|---|---|
| NANO MRNA CO.,LTD. | Chief Executive Officer | 2022-11-30 |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Chief Executive Officer | 2017-02-28 |
Former positions of Shiro Akinaga
| Companies | Position | End |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NANO MRNA CO.,LTD. | Health Technology |
| KYOWA KIRIN CO. LTD. | Health Technology |
| Private companies | 1 |
|---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Shiro Akinaga
